Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow(R) System Under New CMS Code

(NASDAQ:NUWE), MINNEAPOLIS, Aug. 05, 2025 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming fluid management, today announced that the first patients have been successfully treated with Aquadex(R) ultrafiltration therapy in a hospital-based outpatient setting. This milestone reflects a major advancement in the company's mission to improve access to fluid […]

Core Molding Technologies Announces 2026 Leadership Transition

(NYSE MKT:CMT), COLUMBUS, Ohio, Aug. 05, 2025 (GLOBE NEWSWIRE) — Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, industrial and utilities, medium and heavy-duty truck and powersports industries across the United States, Canada and Mexico today

Asklepion Pharmaceuticals Signs Contract to Utilize NetraMark Technology in Phase III Pediatric Cardiac Study

(CNSX:AIAI),(OTC US:AINMF),(Other OTC:AINMF),(Boerse Frankfurt – Freiverkehr:PF0),(CNSX:AIAI.CN), TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company transforming clinical trials today announced it has signed a contract with Asklepion Pharmaceuticals to deploy its NetraAI platform to analyze results from its

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center GlobeNewswire August 05, 2025 IRB Approval from Hadassah Medical Center Follows FDA IND Clearance and Prior Approvals from Additional Clinical Sites Vancouver, Canada, Aug. 05, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind”

OTSAW Awarded National Group Purchasing Agreement and Technology Breakthrough Designation for its Autonomous Mobile Service Robots with Premier, Inc.

OTSAW Awarded National Group Purchasing Agreement and Technology Breakthrough Designation for its Autonomous Mobile Service Robots with Premier, Inc. Premier offers technology breakthrough designations to innovations that offer a major advantage in terms of patient safety, clinical outcomes and operational efficiencies GlobeNewswire August 05, 2025 SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) — Otsaw Limited (“OTSAW,”

ZenaTech Closes a Seventh Drone as a Service (DaaS) Acquisition in North Carolina Expanding its Southeast Region and Government Opportunities

ZenaTech Closes a Seventh Drone as a Service (DaaS) Acquisition in North Carolina Expanding its Southeast Region and Government Opportunities GlobeNewswire August 05, 2025 VANCOUVER, British Columbia, Aug. 05, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a business technology solution provider specializing in AI-powered drones, Drone as a Service

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow(R) System Under New CMS Code

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow(R) System Under New CMS Code Supported by the recent CMS decision to increase the reimbursement rate, which facilitates broader use of the therapy in outpatient settings GlobeNewswire August 05, 2025 MINNEAPOLIS, Aug. 05, 2025 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology

Core Molding Technologies Announces 2026 Leadership Transition

Core Molding Technologies Announces 2026 Leadership Transition CEO Dave Duvall to Retire May 2026, COO Eric Palomaki to Succeed Duvall GlobeNewswire August 05, 2025 COLUMBUS, Ohio, Aug. 05, 2025 (GLOBE NEWSWIRE) — Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products,

Asklepion Pharmaceuticals Signs Contract to Utilize NetraMark Technology in Phase III Pediatric Cardiac Study

Asklepion Pharmaceuticals Signs Contract to Utilize NetraMark Technology in Phase III Pediatric Cardiac Study GlobeNewswire August 05, 2025 TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company transforming clinical trials today announced it has signed a contract with

Integracare Inc. Expands to Ottawa and Hires Kristine McGinn, Director of Integracare East

Integracare Inc., a leader in private home healthcare in Toronto and Mississauga is expanding to Ottawa and the surrounding area. Under the leadership of home care veteran, Kristine McGinn, Integracare aims to provide Ottawa Seniors with the highest quality home care in the area. https://mma.prnewswire.com/media/2741245/Integracare_Inc_Integracare_Inc__Expands_to_Ottawa_and_Hires_Kri.jpg “I am thrilled to announce that I am joining Integracare

Scroll to Top